Petter‐Arnt Hals

963 total citations
29 papers, 789 citations indexed

About

Petter‐Arnt Hals is a scholar working on Molecular Biology, Radiology, Nuclear Medicine and Imaging and Nutrition and Dietetics. According to data from OpenAlex, Petter‐Arnt Hals has authored 29 papers receiving a total of 789 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 5 papers in Radiology, Nuclear Medicine and Imaging and 5 papers in Nutrition and Dietetics. Recurrent topics in Petter‐Arnt Hals's work include Fatty Acid Research and Health (4 papers), Lanthanide and Transition Metal Complexes (4 papers) and Phenothiazines and Benzothiazines Synthesis and Activities (4 papers). Petter‐Arnt Hals is often cited by papers focused on Fatty Acid Research and Health (4 papers), Lanthanide and Transition Metal Complexes (4 papers) and Phenothiazines and Benzothiazines Synthesis and Activities (4 papers). Petter‐Arnt Hals collaborates with scholars based in Norway, Germany and United States. Petter‐Arnt Hals's co-authors include A. N. Øksendal, Svein G. Dahl, E. Holtz, Kazuhisa Furuhama, Ernest S. Harpur, Dilip Worah, Håkan Hall, Per T. Normann, Marit Liland Sandvold and Maria Rius and has published in prestigious journals such as Blood, Cancer Research and Biochemical Pharmacology.

In The Last Decade

Petter‐Arnt Hals

29 papers receiving 755 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Petter‐Arnt Hals Norway 16 250 214 207 73 62 29 789
Gina Song United States 15 305 1.2× 93 0.4× 160 0.8× 185 2.5× 64 1.0× 33 1.1k
G K Radda United Kingdom 14 295 1.2× 55 0.3× 288 1.4× 88 1.2× 26 0.4× 24 894
Ernest S. Harpur United Kingdom 12 173 0.7× 206 1.0× 118 0.6× 30 0.4× 38 0.6× 25 580
Moshe Rogosnitzky United States 14 237 0.9× 302 1.4× 250 1.2× 180 2.5× 29 0.5× 32 1.3k
Franco Luzzani Italy 14 121 0.5× 72 0.3× 126 0.6× 62 0.8× 22 0.4× 37 547
Mechthild Ladwig Germany 16 299 1.2× 120 0.6× 104 0.5× 156 2.1× 288 4.6× 20 880
Sohji Nagase Japan 24 75 0.3× 115 0.5× 383 1.9× 34 0.5× 281 4.5× 74 1.5k
Miloš Sovák United States 16 136 0.5× 40 0.2× 72 0.3× 81 1.1× 77 1.2× 45 549
Yvon Coulais France 13 211 0.8× 72 0.3× 68 0.3× 12 0.2× 115 1.9× 50 559
Richard J. Comi United States 19 116 0.5× 90 0.4× 319 1.5× 49 0.7× 40 0.6× 42 1.3k

Countries citing papers authored by Petter‐Arnt Hals

Since Specialization
Citations

This map shows the geographic impact of Petter‐Arnt Hals's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Petter‐Arnt Hals with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Petter‐Arnt Hals more than expected).

Fields of papers citing papers by Petter‐Arnt Hals

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Petter‐Arnt Hals. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Petter‐Arnt Hals. The network helps show where Petter‐Arnt Hals may publish in the future.

Co-authorship network of co-authors of Petter‐Arnt Hals

This figure shows the co-authorship network connecting the top 25 collaborators of Petter‐Arnt Hals. A scholar is included among the top collaborators of Petter‐Arnt Hals based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Petter‐Arnt Hals. Petter‐Arnt Hals is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Gart, Eveline, Kanita Salic, Martine C. Morrison, et al.. (2021). Krill Oil Treatment Increases Distinct PUFAs and Oxylipins in Adipose Tissue and Liver and Attenuates Obesity-Associated Inflammation via Direct and Indirect Mechanisms. Nutrients. 13(8). 2836–2836. 27 indexed citations
3.
Mödinger, Yvonne, Christiane Schön, Manfred Wilhelm, & Petter‐Arnt Hals. (2019). Plasma Kinetics of Choline and Choline Metabolites After A Single Dose of SuperbaBoostTM Krill Oil or Choline Bitartrate in Healthy Volunteers. Nutrients. 11(10). 2548–2548. 22 indexed citations
4.
Hals, Petter‐Arnt, Xiaoli Wang, Fabiana Piscitelli, Vincenzo Di Marzo, & Yong‐Fu Xiao. (2017). The time course of erythrocyte membrane fatty acid concentrations during and after treatment of non-human primates with increasing doses of an omega-3 rich phospholipid preparation derived from krill-oil. Lipids in Health and Disease. 16(1). 16–16. 15 indexed citations
6.
Stuurman, Frederik E., Emile E. Voest, Ahmad Awada, et al.. (2013). Phase I study of oral CP-4126, a gemcitabine derivative, in patients with advanced solid tumors. Investigational New Drugs. 31(4). 959–966. 29 indexed citations
7.
Knapper, Steven, Timothy Chevassut, Rafael F. Duarte, et al.. (2013). Elacytarabine in relapsed/refractory acute myeloid leukaemia: An evaluation of clinical efficacy, pharmacokinetics, cardiac safety and effects on lipid profile. Leukemia Research. 38(3). 346–351. 2 indexed citations
8.
Hummel-Eisenbeiss, Johanna, Antje Hascher, Petter‐Arnt Hals, et al.. (2013). The Role of Human Equilibrative Nucleoside Transporter 1 on the Cellular Transport of the DNA Methyltransferase Inhibitors 5-Azacytidine and CP-4200 in Human Leukemia Cells. Molecular Pharmacology. 84(3). 438–450. 41 indexed citations
10.
Toft, Kim Gunnar, Svein Olaf Hustvedt, Petter‐Arnt Hals, et al.. (2005). Disposition of perfluorobutane in rats after intravenous injection of Sonazoid™. Ultrasound in Medicine & Biology. 32(1). 107–114. 54 indexed citations
11.
Hals, Petter‐Arnt & Svein G. Dahl. (1995). Metabolism of levomepromazine in man. European Journal of Drug Metabolism and Pharmacokinetics. 20(1). 61–71. 11 indexed citations
12.
Normann, Per T. & Petter‐Arnt Hals. (1995). In vivo stability and excretion of gadodiamide (GdDTPA-BMA), a hydrophilic gadolinium complex used as a contrast enhancing agent for magnetic resonance imaging. European Journal of Drug Metabolism and Pharmacokinetics. 20(4). 307–313. 25 indexed citations
13.
Øksendal, A. N. & Petter‐Arnt Hals. (1993). Biodistribution and toxicity of MR imaging contrast media. Journal of Magnetic Resonance Imaging. 3(1). 157–165. 117 indexed citations
14.
Harpur, Ernest S., et al.. (1993). Preclinical Safety Assessment and Pharmacokinetics of Gadodiamide Injection, a New Magnetic Resonance Imaging Contrast Agent. Investigative Radiology. 28. S28–S43. 135 indexed citations
15.
Svaland, M. G., et al.. (1992). Human Pharmacokinetics of Iodixanol. Investigative Radiology. 27(2). 130–133. 73 indexed citations
16.
Niemi, Pekka, et al.. (1989). Negative gastrointestinal contrast enhancement and image distortion induced by superparamagnetic particles at 0.02 Tesla. Magnetic Resonance Imaging. 7(6). 649–653. 3 indexed citations
17.
Hals, Petter‐Arnt, Håkan Hall, & Svein G. Dahl. (1988). Muscarinic cholinergic and histamine H1 receptor binding of phenothiazine drug metabolites. Life Sciences. 43(5). 405–412. 22 indexed citations
18.
Dahl, Svein G., Edward Hough, & Petter‐Arnt Hals. (1986). Phenothiazine drugs and metabolites: Molecular conformation and dopaminergic, alpha adrenergic and muscarinic cholinergic receptor binding. Biochemical Pharmacology. 35(8). 1263–1269. 19 indexed citations
19.
Hals, Petter‐Arnt, Håkan Hall, & Svein G. Dahl. (1986). Phenothiazine drug metabolites: Dopamine D2 receptor, α1-and α2-adrenoceptor binding. European Journal of Pharmacology. 125(3). 373–381. 41 indexed citations
20.
Hals, Petter‐Arnt & Dag Jacobsen. (1984). Resin Haemoperfusion in Levomepromazine Poisoning: Evaluation of Effect on Plasma Drug and Metabolite Levels. Human Toxicology. 3(6). 497–503. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026